Maze Therapeutics, Inc. (MAZE) vs Phibro Animal Health Corporation (PAHC)
A side-by-side comparison of Maze Therapeutics, Inc. and Phibro Animal Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MAZE
Maze Therapeutics, Inc.
$26.16HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
PAHC
Phibro Animal Health Corporation
$37.01HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — MAZE vs PAHC
growth of $100 · dividends reinvested · last 2yMAZE +65.7% (+28.7%/yr)PAHC +74.1% (+32.0%/yr)PAHC compounded faster over this window
MAZE PAHC
MAZE vs PAHC: by the numbers
- •PAHC is the larger company ($1.50B vs $1.45B market cap).
- •PAHC is profitable (6.57% net margin) while MAZE runs a net loss (-667.95%).
- •PAHC pays a dividend (1.29% yield), while MAZE has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MAZE | PAHC |
|---|---|---|
| P/E ratio | N/A | 15.17 |
| Forward P/E | N/A | 10.57 |
| PEG ratio | N/A | 1.19 |
| P/S ratio | 72.39 | 0.99 |
| P/B ratio | 3.20 | 3.89 |
| EV / EBITDA | N/A | 8.91 |
| FCF yield | N/A | 0.66% |
Profitability
| Metric | MAZE | PAHC |
|---|---|---|
| Gross margin | 0.00% | 33.71% |
| Operating margin | 0.00% | 13.07% |
| Net margin | -667.95% | 6.57% |
| ROE | -29.48% | 25.87% |
| ROIC | -28.63% | 11.91% |
Dividends
| Metric | MAZE | PAHC |
|---|---|---|
| Dividend yield | N/A | 1.29% |
| Payout ratio | N/A | 19.67% |
Growth (annualized)
| Metric | MAZE | PAHC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.75% |
| EPS CAGR (5Y) | N/A | 12.92% |
| FCF CAGR (5Y) | N/A | -12.27% |
| Total return CAGR (5Y) | N/A | 14.40% |
Frequently asked
- Does MAZE or PAHC pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while MAZE has no payments in the available dividend history.
- Is MAZE or PAHC more profitable?
- PAHC runs the higher net margin — MAZE at -667.95% versus PAHC at 6.57%.
Go deeper
Dig into the metrics
Phibro Animal Health P/E ratioPhibro Animal Health dividend yieldMaze Therapeutics ROEPhibro Animal Health ROEMaze Therapeutics operating marginPhibro Animal Health operating marginMaze Therapeutics revenue growthPhibro Animal Health revenue growthMaze Therapeutics free cash flowPhibro Animal Health free cash flow
Maze Therapeutics & Phibro Animal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.